Lung endothelial cells are sensitive to epsilon toxin from Clostridium perfringens

Bokori-Brown M, Kokkinidou M, Savva C, da Costa S, Naylor C, Cole A, Moss D, Basak A, Titball R (2013) Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies. Protein Sci 22:650–659

Popoff M (2011) Epsilon toxin: a fascinating pore-forming toxin. FEBS J 278:4602–4615

Minami J, Katayama S, Matsushita O, Matsushita C, Okabe A (1997) Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol Immunol 41:527–535

Goldstein J, Morris WE, Loidl CF, Tironi-Farinati C, Tironi-Farinatti C, McClane BA, Uzal FA, Fernandez Miyakawa ME (2009) Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats. PLoS One 4:e7065

Adamson RH, Ly JC, Fernandez-Miyakawa M, Ochi S, Sakurai J, Uzal F, Curry FE (2005) Clostridium perfringens epsilon-toxin increases permeability of single perfused microvessels of rat mesentery. Infect Immun 73:4879–4887

Garcia J, Adams V, Beingesser J, Hughes M, Poon R, Lyras D, Hill A, McClane B, Rood J, Uzal F (2013) Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice. Infect Immun 81:2405–2414

Uzal F, Songer J (2008) Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J Vet Diagn Invest 20:253–265

Nagahama M, Sakurai J (1991) Distribution of labeled Clostridium perfringens epsilon toxin in mice. Toxicon 29:211–217

Soler-Jover A, Blasi J, Gómez de Aranda I, Navarro P, Gibert M, Popoff MR, Martín-Satué M (2004) Effect of epsilon toxin-GFP on MDCK cells and renal tubules in vivo. J Histochem Cytochem 52:931–942

Tamai E, Ishida T, Miyata S, Matsushita O, Suda H, Kobayashi S, Sonobe H, Okabe A (2003) Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance. Infect Immun 71:5371–5375

Soler-Jover A, Dorca J, Popoff MR, Gibert M, Saura J, Tusell JM, Serratosa J, Blasi J, Martín-Satué M (2007) Distribution of Clostridium perfringens epsilon toxin in the brains of acutely intoxicated mice and its effect upon glial cells. Toxicon 50:530–540

Finnie JW (1984) Histopathological changes in the brain of mice given Clostridium perfringens type D epsilon toxin. J Comp Pathol 94:363–370

Ghabriel MN, Zhu C, Reilly PL, Blumbergs PC, Manavis J, Finnie JW (2000) Toxin-induced vasogenic cerebral oedema in a rat model. Acta Neurochir Suppl 76:231–236

Zhu C, Ghabriel MN, Blumbergs PC, Reilly PL, Manavis J, Youssef J, Hatami S, Finnie JW (2001) Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB). Exp Neurol 169:72–82

Gardner D (1973) Pathology of Clostridium welchii type-D enterotoxemia. 2. Structural and ultrastructural alterations in tissues of lambs and mice. J Comp Pathol 83:509–524

Morgan KT, Kelly BG, Buxton D (1975) Vascular leakage produced in the brains of mice by Clostridium welchii type D toxin. J Comp Pathol 85:461–466

Finnie JW (1984) Ultrastructural changes in the brain of mice given Clostridium perfringens type D epsilon toxin. J Comp Pathol 94:445–452

Dorca-Arevalo J, Soler-Jover A, Gibert M, Popoff M, Martin-Satue M, Blasi J (2008) Binding of epsilon-toxin from Clostridium perfringens in the nervous system. Vet Microbiol 131:14–25

Li Q, Xin W, Gao S, Kang L, Wang J (2013) A low-toxic site-directed mutant of Clostridium perfringens epsilon-toxin as a potential candidate vaccine against enterotoxemia. Hum Vaccin Immunother 9:2386–2392

Oyston P, Payne D, Havard H, Williamson E, Titball R (1998) Production of a non-toxic site-directed mutant of Clostridium perfringens epsilon-toxin which induces protective immunity in mice. Microbiology 144:333–341

Pelish TM, McClain MS (2009) Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin. J Biol Chem 284:29446–29453

Dorca-Arevalo J, Pauillac S, Diaz-Hidalgo L, Martin-Satue M, Popoff M, Blasi J (2014) Correlation between in vitro cytotoxicity and in vivo lethal activity in mice of epsilon toxin mutants from Clostridium perfringens. PLoS One 9:e102417

Finnie J (2004) Neurological disorders produced by Clostridium perfringens type D epsilon toxin. Anaerobe 10:145–150

Finnie JW, Manavis J, Chidlow G (2014) Loss of endothelial barrier antigen immunoreactivity as a marker of Clostridium perfringens type D epsilon toxin-induced microvascular damage in rat brain. J Comp Pathol 151:153–156

Ghabriel MN, Zhu C, Hermanis G, Allt G (2000) Immunological targeting of the endothelial barrier antigen (EBA) in vivo leads to opening of the blood-brain barrier. Brain Res 878:127–135

Worthington RW, Mulders MS (1977) Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation. Infect Immun 18:549–551

Uzal F, McClane B, Cheung J, Theoret J, Garcia J, Moore R, Rood J (2015) Animal models to study the pathogenesis of human and animal Clostridium perfringens infections. Vet Microbiol 179:23–33

Uzal F, Kelly W, Morris W, Assis R (2002) Effects of intravenous injection of Clostridium perfringens type D epsilon toxin in calves. J Comp Pathol 126:71–75

Uzal F, Rolfe B, Smith N, Thomas A, Kelly W (1999) Resistance of ovine, caprine and bovine endothelial cells to Clostridium perfringens type D epsilon toxin in vitro. Vet Res Commun 23:275–284

Petit L, Gibert M, Gillet D, Laurent-Winter C, Boquet P, Popoff MR (1997) Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J Bacteriol 179:6480–6487

Cole A, Gibert M, Popoff M, Moss D, Titball R, Basak A (2004) Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat Struct Mol Biol 11:797–798

Cheong K, Zacchetti D, Schneeberger E, Simons K (1999) VIP17/MAL, a lipid raft-associated protein, is involved in apical transport in MDCK cells. Proc Natl Acad Sci U S A 96:6241–6248

Rumah K, Ma Y, Linden J, Oo M, Anrather J, Schaeren-Wiemers N, Alonso M, Fischetti V, McClain M, Vartanian T (2015) The myelin and lymphocyte protein MAL is required for binding and activity of Clostridium perfringens epsilon-toxin. PLoS Pathog 11:e1004896

Linden J, Ma Y, Zhao B, Harris J, Rumah K, Schaeren-Wiemers N, Vartanian T (2015) Clostridium perfringens epsilon toxin causes selective death of mature oligodendrocytes and central nervous system demyelination. Mbio 6:e02513

Wioland L, Dupont J, Doussau F, Gaillard S, Heid F, Isope P, Pauillac S, Popoff M, Bossu J, Poulain B (2015) Epsilon toxin from Clostridium perfringens acts on oligodendrocytes without forming pores, and causes demyelination. Cell Microbiol 17:369–388

Blanch M, Dorca-Arevalo J, Not A, Cases M, Gomez de Aranda I, Martinez-Yelamos A, Martinez-Yelamos S, Solsona C, Blasi J (2018) The cytotoxicity of epsilon toxin from Clostridium perfringens on lymphocytes is mediated by MAL protein expression. Mol Cell Biol 38:e00086-18

Millan J, Puertollano R, Fan L, Alonso MA (1997) Caveolin and MAL, two protein components of internal detergent-insoluble membranes, are in distinct lipid microenvironments in MDCK cells. Biochem Biophys Res Commun 233:707–712

Zacchetti D, Peranen J, Murata M, Fiedler K, Simons K (1995) VIP17/MAL, a proteolipid in apical transport vesicles. FEBS Lett 377:465–469

Martin-Belmonte F, Puertollano R, Millan J, Alonso MA (2000) The MAL proteolipid is necessary for the overall apical delivery of membrane proteins in the polarized epithelial Madin–Darby canine kidney and fischer rat thyroid cell lines. Mol Biol Cell 11:2033–2045

Dorca-Arevalo J, Blanch M, Pradas M, Blasi J (2018) Epsilon toxin from Clostridium perfringens induces cytotoxicity in FRT thyroid epithelial cells. Anaerobe 53:43–49

Marazuela M, Acevedo A, Adrados M, Garcia-Lopez M, Alonso M (2003) Expression of MAL, an integral protein component of the machinery for raft-mediated apical transport, in human epithelia. J Histochem Cytochem 51:665–673

Dong Q, Bernasconi S, Lostaglio S, DeCalmanovici R, MartinPadura I, Breviario F, Garlanda C, Ramponi S, Mantovani A, Vecchi A (1997) A general strategy for isolation of endothelial cells from murine tissues—characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler Thromb Vasc Biol 17:1599–1604

Hunter SE, Clarke IN, Kelly DC, Titball RW (1992) Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli. Infect Immun 60:102–110

Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254

Trapero C, Vidal A, Rodriguez-Martinez A, Sevigny J, Ponce J, Coroleu B, Matias-Guiu X, Martin-Satue M (2019) The ectonucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in human endometrium: a novel marker of basal stroma and mesenchymal stem cells. Purinergic Signal 15:225–236

Lewis M, Weaver CD, McClain MS (2010) Identification of small molecule inhibitors of Clostridium perfringens epsilon—toxin cytotoxicity using a cell-based high-throughput screen. Toxins 2:1825–1847

Susurluk H, Toprak U, Oktay Gurkan M (2013) Concentration of sodium dodecyl sulfate used in occlusion body extraction affects Spodoptera littoralis nucleopolyhedrovirus biological activity. Turk J Biol 37:171–175

Dorca-Arevalo J, Martin-Satue M, Blasi J (2012) Characterization of the high affinity binding of epsilon toxin from Clostridium perfringens to the renal system. Vet Microbiol 157:179–189

Uzal FA, Kelly WR, Morris WE, Bermudez J, Baison M (2004) The pathology of peracute experimental Clostridium perfringens type D enterotoxemia in sheep. J Vet Diagn Invest 16:403–411

Petit L, Gibert M, Gourch A, Bens M, Vandewalle A, Popoff MR (2003) Clostridium perfringens epsilon toxin rapidly decreases membrane barrier permeability of polarized MDCK cells. Cell Microbiol 5:155–164

Martin-Belmonte F, Kremer L, Albar J, Marazuela M, Alonso M (1998) Expression of the MAL gene in the thyroid: the MAL proteolipid, a component of glycolipid-enriched membranes, is apically distributed in thyroid follicles. Endocrinology 139:2077–2084